Total Hip Arthroplasty (THA)NCT07163598
PNB Anesthesia Improves Older Patients' Postoperative Early Recovery Outcomes After Total Hip Arthroplasty
An observational study of Total Hip Arthroplasty (THA) and Femoral Neck Fractures, run by RenJi Hospital at 1 site in China.
Trial summary
Early postoperative rehabilitation is an important issue for total hip arthroplasty, especially in older patients. This retrospective clinical trial is to assess the impact of peripheral nerve block anesthesia versus general anesthesia in older patients' early recovery outcomes after total hip arthroplasty. Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Total Hip Arthroplasty (THA), Femoral Neck Fractures
- How many people
- 516 participants
- Where
- 1 siteChina
- Study dates
- 1 Nov 2020to 30 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Older patients who visited Renji Hospital affiliated with Shanghai Jiao Tong University school of medicine for total hip arthroplasty were enrolled between 11/2020 and 12/2024.
Who may be able to join
- patients aged over 60 years; 2. patients underwent total hip replacement; 3. the surgery was done with ultrasound-guided nerve block alone or under general anesthesia.
Who cannot join
- patients who failed to the nerve block and were changed to general anesthesia for the operation; 2. patients who lost contact 3 months after surgery.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Peripheral Nerve Block Anesthesia Improves Older Patients' Postoperative Early Recovery Outcomes After Total Hip Arthroplasty: a Retrospective Clinical Trial
Early postoperative rehabilitation is an important issue for total hip arthroplasty, especially in older patients. This retrospective clinical trial is to assess the impact of peripheral nerve block anesthesia versus general anesthesia in older patients' early recovery outcomes after total hip arthroplasty.
- Being tested
- No Intervention: Observational Cohort
- Keywords
- Total hip arthroplasty, peripheral nerve block anesthesia, QoR-40 score
- Medical subject headings
- Femoral Neck Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No Intervention: Observational CohortOther
This study is a observational cohort study, and we have no intervention.
| Study group | Role | What they receive |
|---|---|---|
| peripheral nerve block group | Not described Receives: Other: No Intervention: Observational Cohort | |
| general anesthesia group | Not described Receives: Other: No Intervention: Observational Cohort |
What is being measured
The primary outcome is the main question the study is designed to answer.
postoperative QoR-40 scores
Measured: 1-day and 3-month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2025
- Study start1 Nov 2020
- Primary completion30 Dec 2024
- Study completion30 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Total Hip Arthroplasty (THA)Studies of the same condition, open and under way.
- More trials run by RenJi HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 516 participants (actual)
Sponsor and investigators
- Lead sponsor
- RenJi Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jie Tian, RenJi Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07163598
- Sponsor's protocol ID
- KY2022-066-B
- Status last verified
- Sep 2025
- First submitted
- 1 Sep 2025
- Last updated
- 9 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Peripheral Nerve Block Anesthesia Improves Older Patients' Postoperative Early Recovery Outcomes After Total Hip Arthroplasty: a Retrospective Clinical Trial
- ClinicalTrials.gov ID
- NCT07163598
- Acronym / sponsor ID
- KY2022-066-B
- Keywords
- Total hip arthroplasty, peripheral nerve block anesthesia, QoR-40 score
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 516 participants (actual)
- Lead sponsor
- RenJi HospitalUniversity, hospital or other
- Study start
- 1 Nov 2020 (actual)
- Primary completion
- 30 Dec 2024 (actual)
- Study completion
- 30 Dec 2024 (actual)
- First posted
- 9 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Early postoperative rehabilitation is an important issue for total hip arthroplasty, especially in older patients. This retrospective clinical trial is to assess the impact of peripheral nerve block anesthesia versus general anesthesia in older patients' early recovery outcomes after total hip arthroplasty.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| peripheral nerve block group | – | Other: No Intervention: Observational Cohort |
| general anesthesia group | – | Other: No Intervention: Observational Cohort |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Older patients who visited Renji Hospital affiliated with Shanghai Jiao Tong University school of medicine for total hip arthroplasty were enrolled between 11/2020 and 12/2024.
Key inclusion criteria (1 listed)
- patients aged over 60 years; 2. patients underwent total hip replacement; 3. the surgery was done with ultrasound-guided nerve block alone or under general anesthesia.
Key exclusion criteria (1 listed)
- patients who failed to the nerve block and were changed to general anesthesia for the operation; 2. patients who lost contact 3 months after surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No Intervention: Observational CohortThis study is a observational cohort study, and we have no intervention. | Other | general anesthesia group, peripheral nerve block group |
Primary outcome
postoperative QoR-40 scores
Time frame: 1-day and 3-month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Total Hip Arthroplasty (THA)
RecruitingPhase 4
PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty
Hip Osteoarthritis, Hip Arthropathy
Not yet recruiting
Effects of Combined Pericapsular Nerve Group (PENG) and Lateral Femoral Cutaneous Nerve (LFCN) Blocks on Anaesthetic Requirements and Electroencephalographic Depth of Anaesthesia During Total Hip Arthroplasty
Total Hip Arthroplasty (THA)
Recruiting
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Osteoarthritis, Traumatic Arthritis
Enrolling by invitationPhase 2
Efficacy of Intravenous Oxytocin to Speed Recovery After THA
Total Hip Arthroplasty
Enrolling by invitationPhase 3
A Clinical Trial Evaluating the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty in China
Pain After Abdominal Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Total Hip Arthroplasty (THA) and Femoral Neck Fractures, run by RenJi Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
postoperative QoR-40 scores (time frame: 1-day and 3-month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.